Gregory Gene Freitag's Net Worth

$6.41 Million

Estimate Recalculated Sep 17, 2024 08:17PM EST

Who is Gregory Gene Freitag

Gregory Gene Freitag has an estimated net worth of $6.41 Million. This is based on reported shares across multiple companies, which include Axogen, Inc., PDS Biotechnology Corp, PRESSURE BIOSCIENCES INC, and ZyVersa Therapeutics, Inc..

SEC CIK

Gregory Gene Freitag's CIK is 0001492710

Past Insider Trading and Trends

2021 was Gregory Gene Freitag's most active year for acquiring shares with 13 total transactions. Gregory Gene Freitag's most active month to acquire stocks was the month of May. 2021 was Gregory Gene Freitag's most active year for disposing of shares, totalling 11 transactions. Gregory Gene Freitag's most active month to dispose stocks was the month of April. 2021 saw Gregory Gene Freitag paying a total of $1,007,400.68 for 165,313 shares, this is the most they've acquired in one year. In 2018 Gregory Gene Freitag cashed out on 137,801 shares for a total of $2,340,120.75, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Axogen, Inc.

General Counsel
Updated Jun 06, 2024
Form 4
Jun 06, 2024
283.50K
Options
Jun 04
Form 4
-8.43%
-25.00K
$9.00
-$225.00K
Mar 08, 2024
271.59K
Sale
Mar 07
Form 4
32.34K
Sep 07, 2023
32.34K
Grant
Sep 01
Form 4
-12.40%
-41.98K
$8.71
-$365.78K
Jun 05, 2023
296.59K
Sale
Jun 01
Form 4
-2.20%
-7.47K
$9.23
-$68.90K
May 24, 2023
332.12K
Sale
May 23
Form 4
-3.69%
-13.00K
$12.74
-$165.62K
Nov 16, 2022
339.58K
Sale
ScheduledNov 14
Form 4
-3.56%
-13.00K
$12.50
-$162.50K
Nov 10, 2022
352.58K
Sale
ScheduledNov 08
Form 4
-2.37%
-8.89K
$9.70
-$86.16K
Aug 11, 2022
365.58K
Sale
ScheduledAug 10
Form 4
-9.00%
-37.05K
$10.54
-$390.65K
Aug 08, 2022
374.47K
Sale
ScheduledAug 04 - Aug 08
Form 4
-6.86%
-30.30K
$6.32
-$0.96
Jul 26, 2022
411.52K
Options
Jul 25
Form 4
5.09%
18.27K
Jun 03, 2022
377.08K
Options
Jun 01
Form 4
-2.41%
-8.78K
$20.05
-$6.38K
Jun 21, 2021
355.78K
Options
Jun 17
Form 4
$3.67
Jun 08, 2021
355.31K
Options
Jun 04
Form 4
9.07K
Jun 03, 2021
9.07K
Grant
Jun 01
Form 4
$6.22
May 28, 2021
331.31K
Options
May 26
Form 4
-9.51%
-24.00K
$22.06
-$529.44K
Mar 01, 2021
228.35K
Sale
ScheduledFeb 25
Form 4
1.44%
3.58K
$18.70
-$29.49K
Feb 18, 2021
252.35K
Grant
Feb 16 - Feb 17
Form 4
0.56%
1.38K
$17.81
-$16.31K
Dec 30, 2020
248.35K
Grant
Dec 27 - Dec 29
Form 4
0.22%
546.00
$16.42
-$6.22K
Dec 22, 2020
245.08K
Grant
Dec 18 - Dec 21
Form 4
$3.67
$47.88K
Sep 17, 2020
291.48K
Options
Sep 15
Form 4
$3.50
$437.50K
Jun 01, 2020
231.48K
Options
May 29
Form 4
36.00K
Mar 18, 2020
36.00K
Grant
Mar 16
Form 4
3.53%
3.63K
$14.68
-$22.48K
Feb 20, 2020
106.48K
Grant
Feb 18
Form 4
1.28%
1.28K
$16.73
-$9.49K
Dec 20, 2019
101.54K
Grant
Dec 18
Form 4
3.49%
3.38K
$17.57
$59.33K
Feb 19, 2019
100.26K
Grant
Feb 15
Form 4
23.10K
Dec 31, 2018
23.10K
Grant
Dec 27
Form 4
-31.95%
-45.00K
$33.00
-$1.48M
Dec 04, 2018
95.87K
Sale
ScheduledNov 30
Form 4
-12.43%
-20.00K
$32.25
-$645.00K
Nov 15, 2018
140.87K
Sale
Nov 15
Form 4
-1.77%
-2.90K
$21.05
$14.00
Mar 23, 2018
160.87K
Options
Mar 21
Form 4
-2.14%
-2.90K
$18.35
$15.25
Mar 05, 2018
132.76K
Options
Mar 01
Form 4
25.80K
Dec 20, 2017
25.80K
Grant
Dec 18
Form 4
-1.06%
-1.45K
$10.82
-$5.00
Sep 27, 2017
135.67K
Options
Sep 25
Form 4
-2.69%
-3.79K
$9.70
-$0.25
Aug 29, 2017
137.12K
Options
Aug 27
Form 4
48.47%
46.00K
$2.74
$63.02K
Mar 14, 2017
140.90K
Options
Dec 30 - Dec 30
Form 4
50.00K
Jan 03, 2017
50.00K
Grant
Dec 29
Form 4
21.00K
May 31, 2016
21.00K
Grant
May 26
Form 4/A
92.00K
May 31, 2016
92.00K
Grant
Aug 06 - Dec 28
Form 4
92.00K
Dec 30, 2015
92.00K
Grant
Aug 06 - Dec 28
Form 4
10.88%
4.80K
$2.75
$13.20K
Feb 12, 2015
48.90K
Grant
Feb 10
Form 4
24.19%
60.00K
Dec 31, 2014
308.00K
Grant
Dec 29
Form 4
6.90%
16.00K
Oct 10, 2014
248.00K
Grant
Oct 01
Form 4
21.38%
5.20K
$2.45
$12.72K
Jun 04, 2014
29.52K
Purchase
Jun 02 - Jun 03
Form 4
8.51%
21.25K
Jan 06, 2014
270.90K
Grant
Jan 02
Form 4
34.27%
8.33K
$3.00
$25.00K
Aug 15, 2013
32.65K
Purchase
Aug 14
Form 4
62.12%
9.32K
$2.40
$22.36K
Jan 03, 2012
24.32K
Purchase
Dec 30
Form 4
92.00K
Dec 28, 2011
92.00K
Grant
Dec 26
Form 4
15.00K
$2.91
$43.65K
Nov 23, 2011
15.00K
Purchase
Nov 21 - Nov 22
Form 4
125.00K
Jun 01, 2010
125.00K
Grant
Jun 01
Form 3
Jun 01, 2010
Showing 49 results

PDS Biotechnology Corp

Investor
Updated Jun 25, 2024
Form 4
9.00K
Jun 25, 2024
9.00K
Grant
Jun 24
Form 4
9.00K
Jul 17, 2023
9.00K
Grant
Jul 14
Form 4
9.00K
Jun 29, 2022
9.00K
Grant
Jun 28
Form 4
36.95%
14.88K
$8.50
$50.00K
Jun 17, 2021
55.15K
Purchase
Jun 15 - Jun 17
Form 4
9.00K
Jun 25, 2020
9.00K
Grant
Jun 23
Form 4
2,052.38%
38.40K
$1.30
$49.92K
Feb 19, 2020
40.27K
Grant
Feb 14
Form 4
9.00K
Jul 01, 2019
9.00K
Grant
Jun 28
Form 3
Mar 25, 2019
1.87K
Showing 8 results

PRESSURE BIOSCIENCES INC

Investor
Updated Apr 10, 2012
Form 4
10.28%
4.38K
Apr 10, 2012
47.05K
Acquisition
Apr 05
Form 4
52.90%
23.98K
$1.88
$50.08K
Oct 07, 2011
69.30K
Options
Sep 30
Form 4
1,301.84%
14.88K
Sep 07, 2011
16.02K
Grant
Sep 02
Form 3
Aug 02, 2010
216.00
Form 4
25.00K
Jul 29, 2010
25.00K
Grant
Jul 27
Showing 5 results

ZyVersa Therapeutics, Inc.

Investor
Updated Jul 18, 2024
Form 4
132.00
Jul 18, 2024
132.00
Grant
May 24
Form 3
Jan 17, 2023
Showing 2 results